검색어: ċiklosporina (몰타어 - 영어)

Ċiklosporina
ciclosporin

ikervis ċiklosporina
ikervis ciclosporin

ikervis fih is-sustanza attiva ċiklosporina.
ikervis contains the active substance ciclosporin.

Ċiklosporina (użat biex irażżan is-sistema immuni).
ciclosporin (used to suppress the immune system).

rapamune għandu jittieħed erba’ sigħat wara kull doża taċ-ċiklosporina.
rapamune should be taken four hours after each ciclosporin dose.

il-mediċini ntużaw bħala żieda maċ-ċiklosporina u mal-kortikosterojdi.
the medicines were used as an add- on to ciclosporin and corticosteroids.

rapamune kien aktar effikaċi minn plaċebo u effikaċi daqs azathioprine, meta kienu miżjudin ma ’ ċiklosporina u kortikosterojdi.
rapamune was more effective than placebo and as effective as azathioprine, when they were added to ciclosporin and corticosteroids.

rapamune kien iktar effettiv mill-plaċebo jew mill-ażjotropina meta żdiedu maċ-ċiklosporina u mal- kortikosterojdi.
rapamune was more effective than placebo or azathioprine, when they were added to ciclosporin and corticosteroids.

jintuża maċ-ċiklosporina u l-kortikosterojdi (mediċini oħra biex jipprevjenu r-rifjut ta’ organi).
it is used with ciclosporin and corticosteroids (other medicines used to prevent organ rejection).

huwa rrakkomandat li rapamune jintuża maċ-ċiklosporina u kortikosterojdi (mediċini oħrajn biex jimpedixxu rifjut tal-organi) għal xahrejn jew tlieta.
it is recommended that rapamune be used with ciclosporin and corticosteroids (other medicines to prevent organ rejection) for two to three months.

jintuża flimkien maċ-ċiklosporina u l-kortikosterojdi (mediċini oħra użati biex jipprevjenu li l-organi ma jiġux aċċettati).
it is used with ciclosporin and corticosteroids (other medicines used to prevent organ rejection).

kura ta’ pazjienti adulti bi psorjażi kronika plaque moderata għal severa, li ma kellhomx risposta għal, jew għandhom xi kontraindikazzjoni għal, jew huma intoleranti għal kuri sistemiċi oħra inkluz ċiklosporina, methotrexate u puva.
treatment of adult patients with moderate to severe chronic plaque psoriasis who have failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapies including ciclosporin, methotrexate and puva.

emselex ma għandux jingħata lil pazjenti flimkien ma 'mediċini bħaċ- ċiklosporina (cyclosporine, għall- pazjenti li kellhom trapjant), il- verapamil (mediċina għall- qalb), l- inibituri tal- proteażi (mediċini bħal ritonavir, użat fil- pazjenti bl- aids), il- ketoconazole u l- itraconazole (użati għat- trattament ta' infezzjonijiet fungali).
emselex should not be used in people who may be hypersensitive (allergic) to darifenacin or any of the other ingredients, and in patients with: • urinary retention (difficulty in passing urine) • gastric retention (when the stomach doesn ’ t empty properly) • uncontrolled narrow-angle glaucoma (increased eye pressure even with treatment) • myasthenia gravis (a disease of the nerves causing muscle weakness). • severe hepatic impairment (severe liver disease). • severe ulcerative colitis (severe inflammation of the large intestine causing ulceration and bleeding) • toxic megacolon (a very serious complication of colitis – see above) emselex should not be given to patients at the same time as medicine such cyclosporine (in transplant patients), verapamil (a heart medicine), protease inhibitors (medicines such as ritonavir, used in aids patients) or ketoconazole and itraconazole (used to treat fungal infections).